ArriVent BioPharma, Inc. (AVBP)
Across 11 earnings reports since Mar 28, 2024, ArriVent BioPharma, Inc. (AVBP) has a clear post-earnings pattern. It moves ±3.76% on average after reporting and finishes higher 27.3% of the time. Its largest post-earnings gain was +3.08% (Nov 10, 2025) and its largest decline was -11.86% (Nov 14, 2024). The next earnings report is predicted for 2026-11-12 (approximate).
Earnings reactions
How AVBP moved on each past earnings report.
Earnings Impact
Total Earnings
11
Avg Abs. Movement
±3.76%
Positive %
27.3%
Negative %
72.7%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 12, 2026 | ☽ POST | -4.68% | open_in_new |
| May 11, 2026 | ☽ POST | -0.21% | open_in_new |
| Mar 05, 2026 | ☽ POST | -7.21% | open_in_new |
| Nov 10, 2025 | ☀ PRE | +3.08% | open_in_new |
Earnings Count
11
Total earnings in dataset
Avg Abs. Movement
±3.76%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20261019 | open_in_new SEC.gov |
| 8-K | 20261013 | open_in_new SEC.gov |
| SCHEDULE 13G | 20261013 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20261008 | open_in_new SEC.gov |
| 8-K | 20261006 | open_in_new SEC.gov |
| 10-Q | 20260812 | open_in_new SEC.gov |
| 8-K | 20260812 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260727 | open_in_new SEC.gov |
| 4 | 20260622 | open_in_new SEC.gov |
| 4 | 20260622 | open_in_new SEC.gov |
Frequently asked about AVBP earnings
When does ArriVent BioPharma, Inc. report earnings next? expand_more
ArriVent BioPharma, Inc. (AVBP)'s next earnings date is approximate for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does AVBP stock move after earnings? expand_more
Over 11 reports, AVBP has moved an average of ±3.76% the session after earnings, closing higher 27.3% of the time.
What was AVBP's biggest post-earnings move? expand_more
AVBP's largest post-earnings gain on record was +3.08% on Nov 10, 2025, and its largest decline was -11.86% on Nov 14, 2024.
Where can I find ArriVent BioPharma, Inc.'s SEC filings? expand_more
All of ArriVent BioPharma, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- American Healthcare REIT, Inc. (AHR) earnings 2026-11-09
- ALICO, INC. (ALCO) earnings 2026-11-09
- Arbutus Biopharma Corp (ABUS) earnings 2026-11-09
- Abacus Global Management, Inc. (ABX) earnings 2026-11-09
- ACCESS Newswire Inc. (ACCS) earnings 2026-11-09
- Aprea Therapeutics, Inc. Common stock (APRE) earnings 2026-11-09
- Aptevo Therapeutics Inc. Common Stock (APVO) earnings 2026-11-09
- Zumiez Inc (ZUMZ) earnings 2026-11-09